US4576693075
US4576693075
Insmed Incorporated
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 21.97B EUR | 23.27B EUR | 35.41B EUR | 37.29B EUR |
Enterprise Value | 21.52B EUR | 23.31B EUR | 35.4B EUR | 37.37B EUR |
Valuation Multiples | ||||
Trailing P/E | -- | -- | -- | -- |
Forward P/E | 129.84x | -- | -- | -- |
Price to Sales | 19.31x | 20.46x | 43.2x | 72.6x |
Price to Book | 28.99x | 30.72x | 50.23x | 50.46x |
EV/Revenue | 18.92x | 20.49x | 43.2x | 72.75x |
EV/EBITDA | -27.07x | -- | -- | -- |
Price to FCF (P/FCF) | -- | -- | -- | -- |
EV/FCF | -- | -- | -- | -- |
FCF Yield | -2.6% | -3.47% | -2.6% | -1.86% |